These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 7702932)
1. [Radiotherapy and concomitant chemotherapy in the treatment of advanced cancers of the uterine cervix]. Resbeut M; Hennequin C Bull Cancer Radiother; 1994; 81(4):437-45. PubMed ID: 7702932 [No Abstract] [Full Text] [Related]
2. [Radiotherapy-chemotherapy combinations in locally advanced cancers of the cervix]. Vincent P; Chauvet B; Serin D; Brewer Y; Berger C; Reboul F Bull Cancer Radiother; 1996; 83(4):377-84. PubMed ID: 9081341 [No Abstract] [Full Text] [Related]
3. [Theoretical justification of combined radio-chemotherapy in cancer of the cervix]. Hennequin C; Maylin C Bull Cancer Radiother; 1996; 83(4):370-6. PubMed ID: 9081340 [No Abstract] [Full Text] [Related]
4. [Inoperable cancers of the cervix: therapeutic perspectives]. Resbeut M Bull Cancer Radiother; 1996; 83(4):385-7. PubMed ID: 9081342 [No Abstract] [Full Text] [Related]
5. [Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR]. Haie-Meder C; Fervers B; Chauvergne J; Fondrinier E; Lhommé C; Guastalla JP; Resbeut M Bull Cancer; 1999 Oct; 86(10):829-41. PubMed ID: 10572234 [TBL] [Abstract][Full Text] [Related]
7. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy. Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536 [TBL] [Abstract][Full Text] [Related]
8. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer. Borowsky ME; Elliott KS; Pezzullo JC; Santoso P; Choi W; Choi K; Abulafia O Bull Cancer; 2005 Feb; 92(2):E19-24. PubMed ID: 15749639 [TBL] [Abstract][Full Text] [Related]
9. Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study. Winter WE; Maxwell GL; Tian C; Sobel E; Rose GS; Thomas G; Carlson JW Gynecol Oncol; 2004 Aug; 94(2):495-501. PubMed ID: 15297194 [TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer. Loizzi V; Cormio G; Vicino M; Selvaggi L Gynecol Obstet Invest; 2008; 65(2):96-103. PubMed ID: 17878736 [TBL] [Abstract][Full Text] [Related]
11. Toxicity after cervical cancer treatment using radiotherapy and chemotherapy. Jones B Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):56-63. PubMed ID: 19046625 [TBL] [Abstract][Full Text] [Related]
12. [Cancer of the uterine cervix: combination of radiotherapy and cisplatin chemotherapy (chemoradiotherapy) is superior to radiotherapy alone in local advanced stages]. Mazeron JJ Bull Cancer; 1999 Mar; 86(3):247-8. PubMed ID: 10847719 [No Abstract] [Full Text] [Related]
13. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study. Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371 [TBL] [Abstract][Full Text] [Related]
14. [Concomitant chemoradiotherapy in the treatment of carcinoma of the uterine cervix]. Kalábová R; Soumarová R; Seneklová Z Cas Lek Cesk; 2003; 142 Suppl 1():44-50. PubMed ID: 12924051 [TBL] [Abstract][Full Text] [Related]
15. [Chemoradiotherapy: innovation in treatment of high-risk cervical cancer]. Piura B; Meirovitz M Harefuah; 2000 Mar; 138(6):482-7. PubMed ID: 10883165 [No Abstract] [Full Text] [Related]
16. Combined radiation therapy and chemotherapy for carcinoma of the cervix. Rose PG; Eifel PJ Cancer J; 2001; 7(2):86-94. PubMed ID: 11324770 [TBL] [Abstract][Full Text] [Related]
17. [Cancers of the cervix uteri stages IIB acute and III. Results of trials combining chemotherapy to treatments with radiotherapy and/or surgery]. Haie-Meder C; Lhomme C; Gerbaulet A Pathol Biol (Paris); 1993 Jan; 41(1):73-4. PubMed ID: 8316478 [No Abstract] [Full Text] [Related]
18. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904 [TBL] [Abstract][Full Text] [Related]
19. Optimal therapy for relapsed carcinoma of the cervix after primary chemoradiation. Mano M; Kerr J J Clin Oncol; 2004 Dec; 22(24):5021-2; author reply 5022. PubMed ID: 15611523 [No Abstract] [Full Text] [Related]
20. [New therapeutic plans for cancer of the cervix]. Querleu D; Leblanc E; Castelain B; Lanvin D; Denoit V J Gynecol Obstet Biol Reprod (Paris); 2000 May; 29(3):254-7. PubMed ID: 10804364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]